Find a TenderPast planning noticePreliminary market engagement notice
Published 21 Aug 2025, 10:13 BST

Official UK procurement notice

Radiopharmaceutical Manufacturing Unit · UK public procurement notice

Official notice

Authority: Guy's and St Thomas' NHS Foundation Trust (Central government)

ServicesAbove threshold
Planned pipeline value£69,000,000pipeline notice, not a live tender
Tender notice expected 1 Oct 2025from the planned procurement notice
Contract term 12 yrsends 31 May 2038 · up to 31 May 2043 with extensions · starts 1 Jun 2026

What is being bought

Published requirement description

GSTT is seeking to commission an industry partner to design, build and operate a new, purpose-built Good Manufacturing Practice (GMP)-compliant Radiopharmaceutical Manufacturing Unit to support the growing demand for diagnostic (SPECT and PET) and therapeutic radiopharmaceuticals within close proximity of GSTT. It is anticipated a unit of 1,240 m2 within 1.5 miles of Guy’s Hospital will be leased by GSTT and discussions with the landlord are progressing. This initiative aims to establish a hub-and-spoke model, where the new unit will serve as the central hub, and the existing facility at Guy’s Hospital will continue as a spoke. This strategic development will:

  • Increase manufacturing capacity for routine diagnostics and advanced clinical trials for GSTT and for the wider London market.
  • Ensure equity of patient access to the latest RP diagnostics and therapeutics.
  • Support innovative clinical research.
  • Help future-proof Radiopharmacy services by adapting to evolving market demands.
  • Develop the Radiopharmacy workforce through education and training programmes to ensure they are equipped with the skills and expertise needed to meet the evolving demands of the industry.

This initiative is part of GSTT’s strategic vision to lead in nuclear medicine, enhancing patient access to advanced diagnostics and therapies while driving innovation in radiopharmaceutical production. The new unit will also serve as a centre for education and training, developing the next generation of radiopharmacists and strengthening GSTT’s role as a leader in clinical research and healthcare excellence.

The Estimated Total Contract Value including VAT detailed below is illustrative and VAT will only be charged if applicable.

CPV: Diagnostic agents · Diagnostics and radiodiagnostic devices and supplies · Medical consumables · Pharmaceutical products · Pharmacy services · Radioactive materials · Radiotherapy devices and supplies · Radiotherapy supplies · Services provided by medical laboratories

The lotProcurement structure

single lot · no lot value published
Lot #1PlannedRenewal 12 yrs

Procedure terms & legal framework

From the official record
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Services
Notice status
Past planning notice
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
21 Aug 2025, 10:13 BST
Last source update
21 Aug 2025, 10:13 BST
Authority reference
ST23-P026
FTS notice number
2025/S 000-050413
Latest notice
Preliminary market engagement notice (UK2)
Classification (CPV)
Diagnostic agentsDiagnostics and radiodiagnostic devices and suppliesMedical consumablesPharmaceutical productsPharmacy servicesRadioactive materialsRadiotherapy devices and suppliesRadiotherapy suppliesServices provided by medical laboratories
Delivery area
London (UKI)
Official registry OCID
ocds-h6vhtk-058bd9 Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

21 Aug 2025 → 1 Jun 2026 · 4 dates
  1. Planning notice published
    21 Aug 2025, 10:13 BST
  2. Tender notice expected390 days ago
    1 Oct 2025, 23:59 BST
  3. Market engagement390 days ago
    1 Oct 2025, 23:59 BST

    1 Introduction

    Guy’s and St Thomas’ NHS Foundation Trust (GSTT/the Trust) is pleased to announce an upcoming virtual market engagement event on Friday 19th September 2025 (11:30 – 12:30), in the form of a panel discussion with key stakeholders from GSTT. GSTT invites industry partners to participate in this engagement exercise to explore an exciting Managed Service Agreement (MSA) opportunity for the design, build and delivery of a Radiopharmacy Manufacturing Unit and Services for the Trust.

    This event aims to introduce the MSA opportunity, gather industry insights, and foster collaboration to shape the future of Radiopharmacy services at GSTT.

    2 Objectives of the Market Engagement Event

    The panel discussion will:

    • Introduce the MSA opportunity and outline GSTT’s strategic vision for the new unit.
    • Test and refine the service model and financial framework to ensure alignment with supplier capabilities and market expectations.
    • Engage with industry stakeholders to gather insights and feedback on the procurement approach and specifications.
    • Foster collaboration and explore potential strategic partnerships with industry leaders.

    3 Scope of the MSA Opportunity

    The MSA opportunity will encompass:

    • Design, build, and operation of a future-proofed state-of-the-art GMP-compliant Radiopharmaceutical Manufacturing Unit.
    • Aseptic manufacturing of diagnostic (SPECT and PET) and therapeutic radiopharmaceuticals for both routine use and clinical trials.
    • Production of investigational medicinal products (IMP) to support innovative clinical research.
    • Integration with existing GSTT pathways, ensuring high standards of patient safety and quality assurance.
    • Cell labelling services.

    This partnership will require operational excellence, regulatory compliance, and the ability to adapt to evolving market demands. It is anticipated the MSA contract will be awarded for a period of 12 years with an option to extend by a further 5 years. The contract value (exclusive of VAT) is estimated to be £42m for the first 12 years and £27m for the optional extension (total £69m)

    1. Managed Service Agreement (MSA)

    A Managed Service Agreement (MSA) is a contract between an organisation (GSTT) and an external provider (the Supplier) to deliver and manage specific services or operations over an agreed period. Under an MSA, the supplier is responsible for end-to-end management, including staffing, equipment, maintenance, and compliance, ensuring that the service is delivered efficiently and consistently, in accordance with GSTT requirements.

    1. Approach to procurement

    GSTT is planning to undertake a Competitive Flexible Procedure under the Procurement Act 2023 to select the right partner. To ensure transparency and gather industry insights, GSTT is hosting this virtual market engagement event to outline the project’s scope, expectations, and strategic direction. This will be followed by an opportunity for an individual meeting with GSTT to explore the opportunity in more detail.

    Please confirm your attendance by Wednesday 17th September 2025.

  4. Contract starts148 days ago
    1 Jun 2026, 00:00 BST

Notice history

1 event · 1 release on Find a Tender
  1. Preliminary market engagement notice published
    21 Aug 2025, 10:13 BST
    UK2

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

Guy's and St Thomas' NHS Foundation Trust

Contracting authorityPublic authority - central government GB-PPON: PDZC-6438-DGPX Great Maze Pond, London, London, SE1 9RTContact name, email

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure